Stability Studies SOP

The purpose of this SOP is to define the procedure for preparing a comprehensive stability testing plan that meets the requirements of various global regulatory authorities, including the US FDA, EMA, and WHO. This plan ensures that drug products maintain their quality, safety, and efficacy throughout their intended shelf life.
Click to read the full article.

The purpose of this SOP is to establish a procedure for conducting stability studies for complex generic drug products in compliance with US FDA guidelines. This ensures that these products meet all required standards of quality, safety, and efficacy throughout their shelf life.
Click to read the full article.

The purpose of this SOP is to define the procedures for implementing the ICH Q1A(R2) guidelines for the stability testing of active pharmaceutical ingredients (APIs) and drug products. This ensures that products maintain their quality, safety, and efficacy throughout their shelf life.
Click to read the full article.

The purpose of this SOP is to establish a procedure for conducting stability testing of breakthrough therapy drugs in compliance with US FDA guidelines. This ensures that these drugs maintain their intended quality, safety, and efficacy throughout their accelerated development and approval process.
Click to read the full article.

The purpose of this SOP is to define the procedures for conducting stability testing of biologics under biosimilar regulatory guidelines. This ensures that biosimilar products meet the required standards of quality, safety, and efficacy throughout their shelf life.
Click to read the full article.

The purpose of this SOP is to establish a procedure for conducting stability testing of non-oral dosage forms (e.g., injectables, topical, inhalation) in compliance with relevant regulatory guidelines. This ensures that these products maintain their intended quality, safety, and efficacy throughout their shelf life.
Click to read the full article.

The purpose of this SOP is to define the procedure for conducting stability studies for drugs with a narrow therapeutic index in compliance with US FDA guidelines. This ensures that these drugs maintain their safety, efficacy, and quality throughout their shelf life.
Click to read the full article.

The purpose of this SOP is to establish a procedure for conducting stability testing of high-risk drug products in compliance with relevant regulatory guidelines. This ensures that these products maintain their safety, efficacy, and quality throughout their shelf life.
Click to read the full article.

The purpose of this SOP is to establish a procedure for conducting stability testing for products under Emergency Use Authorization (EUA) in compliance with regulatory guidelines. This ensures that products maintain their quality, safety, and efficacy throughout the duration of their emergency use.
Click to read the full article.

The purpose of this SOP is to establish a procedure for conducting stability studies for controlled drugs in compliance with relevant regulatory guidelines. This ensures that controlled substances maintain their quality, safety, and efficacy throughout their shelf life.
Click to read the full article.